PUBLISHER: DataM Intelligence | PRODUCT CODE: 1374887
PUBLISHER: DataM Intelligence | PRODUCT CODE: 1374887
Ear tubes (also anointed myringotomy tubes or tympanostomy tubes) are tiny tubes that are surgically positioned in the child's eardrum by a pediatric ear, nose, and throat (ENT) surgeon to aid in treating ear infections.
The purpose of the tube is to provide ventilation to the middle ear and prevent liquid buildup. The primary indication for the usage of this tube is eustachian tube dysfunction directing to otitis media with effusion or serous otitis media. These tympanostomy tubes deliver ventilation, equalize tension in the middle ear, and avert further recurrent infections.
The high prevalence of pediatric ear infections is expected to boost the global market growth during the forecast period. For instance, according to Johns Hopkins University, ear infections in infants and toddlers are extremely typical. Moreover, according to the National Institutes of Health, five in six children are expected to encounter an ear infection before the age of 3. Over 80% of children have at least one ear infection by the time they are 3 years old. In the U.S., ear infections make up for almost 30 million visits to the pediatrician each year the most common reason children visit their doctor.
Furthermore, growing technological advancements and growing awareness among others are expected to contribute to the global market growth during the forecast period.
Putting in an ear tube carries a risk of serious problems including bleeding, infection, ongoing fluid drainage, blocked tubes from blood or mucus, eardrum scarring or weakening, tubes falling out too soon or staying in too long and the eardrum not closing after the tube falls out or is taken out, hampering the global market growth during the forecast period. Moreover, other restraining factors include stringent regulatory bodies, high product development costs, low awareness and avalibility of substituents among others.
The global tympanostomy tube market is segmented based on material, application, end user and region.
Acute otitis media (AOM) is described as an infection of the middle ear and is the second most typical pediatric infection diagnosis in the emergency division following upper respiratory infections. Although acute otitis media can transpire at any age, it is highly typical to be detected between the ages of 6 to 24 months. The high prevalence of acute otitis media is expected to boost segment growth during the forecast period.
For instance, according to NIH, roughly 80% of all children are estimated to experience a case of otitis media in their lifetime, and between 80% to 90% of all children are expected to have otitis media with an effusion before school age. Moreover, according to the American Academy for Pediatrics, more than 5,000,000 AOM cases surface annually in US children.
Owing to the high prevalence and increasing adoption of Tympanostomy Tube treatment in North America the region is estimated to dominate the global market throughout the forecast period. For instance, in 2021, an NIH investigation documented that ear infections were among the most typical infections in United States children yearly.
Moreover, according to the National Institute on Deafness and Other Communication Disorders in March 2021, 5 out of 6 children in the United States experience ear infection by the time they are three years old. Further, in August 2022, Phoenix Children's Hospital executed an ear tube replacement surgery utilizing the Hummingbird tympanostomy tubes on a patient under two years old with a constant ear infection in the United States.
It is confirmed that the COVID-19 pandemic has directed to significant transformations in healthcare delivery, with telehealth evolving more widely embraced to minimize transmission. New policies were also issued, which outlined new protocols for evaluating and managing common pediatric ear, nose, and throat infections.
These modifications have in some cases postponed or substituted surgical interventions. Further, ongoing investigation has directed to new understandings into the pathophysiology of specific pediatric diseases, including otitis media, which suggests that upper respiratory infection exposure may play a larger role than previously thought.
The major global players in the market include: EON Meditech Pvt. Ltd, Atos Medical, Medtronic PLC, Olympus Corporation, Preceptis Medical, Smith & Nephew, Integra Lifesciences Corporation, Grace Medical, Summit Medical LLC and Koken Co., Ltd. Among others.
The global tympanostomy Tube market report would provide approximately 61 tables, 57 figures and 186 pages.
LIST NOT EXHAUSTIVE